Peptide YY Dosage Guide: Research Protocols, Timing & Reconstitution

Standard Dosage Range

Research dosing range: Variable, typically weight-based (mcg/kg)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Weight Management (Research Setting)

0.4-0.8 pmol/kgContinuous infusion

Duration

24 hours

Administered intravenously. This dosage range has shown appetite-suppressing effects in clinical studies. Continuous infusion is often used in research.

Diabetes Management (Research Setting)

Variable (mcg/kg)Multiple daily injections or continuous infusion

Duration

Days to weeks (in research protocols)

Specific dosage varies based on the study protocol. Typically, administered subcutaneously or intravenously. Focus is on improving glucose control.

Appetite Regulation (Investigational)

To be determined (mcg/kg)Variable

Duration

Variable

Further research is needed to establish optimal dosing for appetite regulation outside of research settings. Subcutaneous administration is a practical option.

Timing & Frequency

In research studies, intravenous infusions are often continuous over 24 hours. Subcutaneous injections may be given before meals or at specific intervals throughout the day, depending on the study design.

Cycle Guidance

Due to the limited long-term human safety data, particularly with chronic administration, cycling is a prudent approach. Cycling duration would depend on the specific indication and individual response.

Reconstitution Reference

Quick reference for reconstituting Peptide YY. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial Size	Typically varies based on manufacturer.
BAC Water Volume	As needed for desired concentration (refer to manufacturer instructions).
Concentration & Draw	Variable depending on reconstitution protocol.
Storage	Refrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
Stability	Refer to manufacturer specifications. Reconstituted solutions are generally stable for a limited time (e.g., days) under refrigeration.

Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the primary route of administration for PYY3-36?

PYY3-36 is typically administered intravenously in research settings. Subcutaneous administration is being explored, but IV administration provides more controlled delivery in a research environment.

What dosage has been used in human clinical trials?

Dosage varies, but studies have used continuous intravenous infusions of PYY3-36 at rates around 0.4-0.8 pmol/kg to study appetite suppression and metabolic effects.

Is there an oral form of PYY3-36?

Currently, oral bioavailability of PYY3-36 is very low due to enzymatic degradation in the gastrointestinal tract. Research is ongoing to explore potential oral delivery methods, such as encapsulation or protease inhibitors, to improve absorption.